Eps Summary of Basilea Pharmaceutica AG

Basilea Pharmaceutica AG's latest annual eps in 2023 was 0.86 CHF , down -14.71% from previous year.
Basilea Pharmaceutica AG's latest quarterly eps in 2024 Q2 was 0.81 CHF , down 0.0% from previous quarter.
Basilea Pharmaceutica AG reported an annual eps of 1.02 CHF in 2022, up 275.86% from previous year.
Basilea Pharmaceutica AG reported an annual eps of -0.58 CHF in 2021, up 59.44% from previous year.
Basilea Pharmaceutica AG reported a quarterly eps of 0.81 CHF for 2024 Q2, down 0.0% from previous quarter.
Basilea Pharmaceutica AG reported a quarterly eps of 1.21 CHF for 2023 Q1, down -40.69% from previous quarter.

Annual Eps Chart of Basilea Pharmaceutica AG (2023 - 2012)

Historical Annual Eps of Basilea Pharmaceutica AG (2023 - 2012)

Year	Eps	Eps Growth
2023	0.86 CHF	-14.71%
2022	1.02 CHF	275.86%
2021	-0.58 CHF	59.44%
2020	-1.43 CHF	31.25%
2019	-2.08 CHF	28.03%
2018	-2.89 CHF	-61.45%
2017	-1.79 CHF	64.69%
2016	-5.07 CHF	16.75%
2015	-6.09 CHF	-46.04%
2014	-4.17 CHF	-22.65%
2013	-3.40 CHF	38.52%
2012	-5.53 CHF	0.0%

Year	Eps	Eps Growth
2024 Q1	0.81 CHF	145.51%
2024 Q2	0.81 CHF	0.0%
2023 Q1	1.21 CHF	-40.69%
2023 Q4	-1.78 CHF	-87.37%
2023 Q3	-0.95 CHF	-135.71%
2023 Q2	2.66 CHF	119.83%
2023 FY	- CHF	-14.71%
2022 Q1	-0.52 CHF	-147.27%
2022 Q4	2.04 CHF	101.98%
2022 Q3	1.01 CHF	198.06%
2022 Q2	-1.03 CHF	-98.08%
2022 FY	- CHF	275.86%
2021 Q2	-1.72 CHF	-86.96%
2021 Q4	1.10 CHF	100.0%
2021 FY	- CHF	59.44%
2021 Q1	-0.92 CHF	59.47%
2021 Q3	0.55 CHF	131.98%
2020 FY	- CHF	31.25%
2020 Q1	0.46 CHF	170.77%
2020 Q4	-2.27 CHF	-80.16%
2020 Q2	0.92 CHF	100.0%
2020 Q3	-1.26 CHF	-236.96%
2019 FY	- CHF	28.03%
2019 Q4	-0.65 CHF	-103.13%
2019 Q1	-0.72 CHF	-75.61%
2019 Q3	-0.32 CHF	77.78%
2019 Q2	-1.44 CHF	-100.0%
2018 FY	- CHF	-61.45%
2018 Q3	-0.41 CHF	60.58%
2018 Q2	-1.04 CHF	0.0%
2018 Q1	-1.04 CHF	-2065.97%
2018 Q4	-0.41 CHF	0.0%
2017 Q1	-0.95 CHF	18.1%
2017 Q4	0.05 CHF	0.0%
2017 FY	- CHF	64.69%
2017 Q2	-0.95 CHF	0.0%
2017 Q3	0.05 CHF	105.57%
2016 Q2	-1.38 CHF	0.0%
2016 Q3	-1.16 CHF	15.94%
2016 Q4	-1.16 CHF	0.0%
2016 FY	- CHF	16.75%
2016 Q1	-1.38 CHF	10.97%
2015 FY	- CHF	-46.04%
2015 Q3	-1.55 CHF	-3.33%
2015 Q2	-1.50 CHF	0.0%
2015 Q1	-1.50 CHF	-36.36%
2015 Q4	-1.55 CHF	0.0%
2014 Q2	-0.98 CHF	0.0%
2014 FY	- CHF	-22.65%
2014 Q4	-1.10 CHF	0.0%
2014 Q3	-1.10 CHF	-12.24%
2014 Q1	-0.98 CHF	-22.5%
2013 Q3	-0.80 CHF	11.11%
2013 FY	- CHF	38.52%
2013 Q4	-0.80 CHF	0.0%
2013 Q2	-0.90 CHF	0.0%
2013 Q1	-0.90 CHF	6.25%
2012 FY	- CHF	0.0%
2012 Q3	-0.96 CHF	0.0%
2012 Q4	-0.96 CHF	0.0%

Peer Eps Comparison of Basilea Pharmaceutica AG

Name	Eps	Eps Difference
Eiger BioPharmaceuticals, Inc.	-50.78 USD	101.694%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
SQZ Biotechnologies Company	-2.76 USD	131.159%
Evofem Biosciences, Inc.	10.35 USD	91.691%
Santhera Pharmaceuticals Holding AG	5.95 USD	85.546%
Mesoblast Limited	-0.09 USD	1065.208%
Propanc Biopharma, Inc.	-0.02 USD	3728.692%
Genus plc	0.12 USD	-616.667%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	136.91%
CNBX Pharmaceuticals Inc.	-0.42 USD	304.762%
Marizyme, Inc.	-1.44 USD	159.722%
ContraFect Corporation	-124.97 USD	100.688%
Nymox Pharmaceutical Corporation	-0.10 USD	991.192%
PsyBio Therapeutics Corp.	-0.04 USD	2147.619%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	7266.667%
Intellipharmaceutics International Inc.	-0.09 USD	1083.982%
AXIM Biotechnologies, Inc.	-0.04 USD	2529.379%
MultiCell Technologies, Inc.	-0.00 USD	860100.0%
Accustem Sciences Inc.	-0.34 USD	352.941%
RVL Pharmaceuticals plc	-0.58 USD	248.276%
EV Biologics, Inc.	-0.12 USD	816.667%
Q BioMed Inc.	-0.08 USD	1201.152%
Emmaus Life Sciences, Inc.	-0.07 USD	1323.329%
Neon Bloom, Inc.	-0.00 USD	57433.333%
Mosaic ImmunoEngineering Inc.	-0.33 USD	360.606%
Biomind Labs Inc.	-0.02 USD	5408.642%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	-0.02 USD	5441.615%
Oncotelic Therapeutics, Inc.	-0.02 USD	4421.608%
Skye Bioscience, Inc.	-5.37 USD	116.015%
Therapeutic Solutions International, Inc.	-0.00 USD	122957.143%
THC Farmaceuticals, Inc.	-0.00 USD	107600.0%
Arch Therapeutics, Inc.	-2.27 USD	137.885%
IMV Inc.	-4.37 USD	119.68%
Acro Biomedical Co., Ltd.	-0.26 USD	430.769%
Curative Biotechnology, Inc.	-0.01 USD	9872.727%
GB Sciences, Inc.	-0.00 USD	21075.61%
Alpha Cognition Inc.	-0.15 USD	673.333%
HST Global, Inc.	-0.03 USD	3182.437%
CSL Limited	2.73 USD	68.498%
Halberd Corporation	-0.00 USD	860100.0%
Enzolytics Inc.	-0.00 USD	122957.143%
Resverlogix Corp.	-0.01 USD	6156.338%
Affymax, Inc.	-0.39 USD	320.513%
SYBLEU INC	-0.02 USD	5014.286%
Nuo Therapeutics, Inc.	-0.08 USD	1240.584%
argenx SE	-5.16 USD	116.667%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	-0.06 USD	1595.652%
Enzon Pharmaceuticals, Inc.	0.00 USD	-66053.846%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	-0.04 USD	2508.964%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	4400.0%
AVAX Technologies, Inc.	-0.05 USD	1695.547%
Zenith Capital Corp.	-0.07 USD	1330.329%
Genscript Biotech Corporation	-0.05 USD	1994.273%
Ember Therapeutics, Inc.	-0.01 USD	13750.794%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	122.812%
WPD Pharmaceuticals Inc.	-0.00 USD	172100.0%
American Oriental Bioengineering, Inc.	-781.24 USD	100.11%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	11721.622%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	-4.70 USD	118.298%
GlobeStar Therapeutics Corporation	-0.00 USD	35933.333%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	-36.39 USD	102.363%
Cotinga Pharmaceuticals Inc.	-0.09 USD	1041.95%
BioStem Technologies, Inc.	-0.62 USD	238.71%
ONE Bio Corp.	1.43 USD	39.86%
Reve Technologies, Inc.	-0.01 USD	7326.891%
Burzynski Research Institute, Inc.	-0.01 USD	8531.373%
Wesana Health Holdings Inc.	-0.05 USD	1816.567%
Agentix Corp.	-0.04 USD	2557.143%
LadRx Corporation	0.68 USD	-26.471%
Cell Source, Inc.	-0.17 USD	605.882%
ProtoKinetix, Incorporated	-0.01 USD	8700.0%
Regen BioPharma, Inc.	0.29 USD	-196.552%
Regen BioPharma, Inc.	0.26 USD	-230.769%
NovAccess Global Inc.	-0.23 USD	473.913%
Endonovo Therapeutics, Inc.	0.03 USD	-3326.295%
Itoco Inc.	-0.01 USD	11415.789%
Rasna Therapeutics, Inc.	-0.01 USD	8700.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	34500.0%
Kadimastem Ltd	-0.78 USD	210.256%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	1769.903%
CytoDyn Inc.	-0.05 USD	1725.709%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	172100.0%
Mobile Lads Corp.	-0.01 USD	15457.143%
NanoSphere Health Sciences Inc.	-0.02 USD	3973.874%
Qrons Inc.	-0.06 USD	1575.129%
Alseres Pharmaceuticals, Inc.	-153.67 USD	100.56%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	-0.01 USD	6517.91%
Rebus Holdings, Inc.	-0.03 USD	2779.128%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	6156.338%
International Stem Cell Corporation	-0.02 USD	5343.902%
Bioxytran, Inc.	-0.03 USD	2795.925%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	-0.00 USD	860100.0%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	-7.99 USD	110.763%
Adhera Therapeutics, Inc.	-1.18 USD	172.881%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	-0.03 USD	2629.412%
Innovation Pharmaceuticals Inc.	-0.01 USD	13750.794%
Neutra Corp.	-0.00 USD	860100.0%
Windtree Therapeutics, Inc.	-94.23 USD	100.913%
PureTech Health plc	-2.38 USD	136.134%
Coeptis Therapeutics, Inc.	-0.83 USD	203.614%
IXICO plc	-0.02 USD	3624.59%
IntelGenx Technologies Corp.	-0.06 USD	1614.085%
Gelesis Holdings, Inc.	-1.35 USD	163.704%
CSL Limited	5.47 USD	84.278%
Cellectis S.A.	-1.77 USD	148.588%

Global Stocks Search

Basilea Pharmaceutica AG (BPMUF)

Eps Summary of Basilea Pharmaceutica AG

Annual Eps Chart of Basilea Pharmaceutica AG (2023 - 2012)

Historical Annual Eps of Basilea Pharmaceutica AG (2023 - 2012)

Peer Eps Comparison of Basilea Pharmaceutica AG